Immune Monitor - December 2021

By SITC Communications posted 12-23-2021 00:00

  

A Message from the President

Dear Colleagues,

The 36th Annual Meeting & Pre-Conference Programs (SITC 2021) is in the rearview mirror and it was such a huge success. There was a record number of abstract submissions, an amazing Richard V. Smalley Memorial Lecture from Crystal Mackall, MD on CAR T Cells for Solid Tumors, as well as a recap of Project Lightspeed with Uğur Şahin, MD and Özlem Türeci, MD from BioNTech. We also honored many of the SITC award winners and unveiled our inaugural class of the Fellows of the Academy of Immuno-Oncology.

The Fireside Chat for December is a discussion on the Best of SITC 2021. To provide a few different points of view on the highlights from the 36th Annual Meeting held last month, I was able to sit down with Ana Carrizosa Anderson, PhD – Harvard Medical School and Robert L. Ferris, MD, PhD – UPMC Hillman Cancer Center to get their perspective on the science that was delivered at the meeting.
During our chat, we discussed the session on COVID vaccines and how the findings can improve cancer vaccines. With an incredible 5,000 people attending SITC 2021, the discussion continued with reflections on the new hybrid nature of this year’s show. The Exhibit Hall is always a place for connecting with industry and colleagues; Dr. Ferris gave his thoughts on the abstracts showcased there as well as the many exhibitors. We also heard from Dr. Anderson on some of the exciting new initiatives that were discussed at the SITC Board of Directors meeting – the development of partnerships with engineers and efforts around Diversity, Equity and Inclusion.

Our exchange left me excited for the coming year and especially for next year’s meeting. I want to thank both Dr. Anderson and Dr. Ferris for their feedback on the event and I look forward to seeing all of you at next year’s meeting in Boston. Happy Holidays!

Sincerely,


Patrick Hwu, MD

SITC President



Register to Attend the Hybrid 2022 SITC Cancer Immunotherapy Winter School

Jan. 24–28, 2022 · Austin, TX · In Person and Virtual

SITC is pleased to host its fourth annual and first hybrid Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program. This program is offered in a hybrid format with opportunities to participate in Austin, TX and virtually! SITC is excited to offer this as a hybrid program, providing the opportunity to garner a wider group of professionals. We are proud to present the best in cancer immunotherapy education, whether you plan to travel or attend remotely.

Taught by leading experts in the field, this program provides a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as developing areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis and considerations for combination therapies.

Winter School Organizers:

  • Catherine Bollard, MBChB, MD – Children’s National Hospital
  • Christian Capitini, MD – University of Wisconsin-Madison
  • Daniel Powell, PhD – University of Pennsylvania

Hotel reservations deadline has been extended to Jan. 3. Book now in the SITC block.

Register now to confirm your attendance.

Join SITC in Learning the Latest Advances in Cancer ImmunotherapyTM: A Focus on Head and Neck Cancers

SITC’s ACI educational programming series is FREE for all healthcare professionals in the clinical setting, students and patient advocates!

Join SITC on Wednesday, Jan. 12, 2022, for its live virtual Advances in Cancer ImmunotherapyTM (ACI): A Focus on Head and Neck Cancers program, hosted on Zoom Webinar. This meeting is part of the newly redesigned Advances in Cancer ImmunotherapyTM (ACI) educational series, with each program offering focused clinical education on a disease state or topic. Attendees of these half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for head and neck cancers from leaders in this specific field, including training on the latest approvals and treatment recommendations, toxicity management, and biomarkers considerations. The ACI program will also feature a discussion of cases submitted from attendees to hear guidance and insights from expert faculty. This meeting is certified for CME, CNE, CPE, and MOC credits.

ACI: A Focus on Head and Neck Cancers Organizers:

  • Jessica R. Bauman, MD – Fox Chase Cancer Center
  • Jessica L. Geiger, MD – Cleveland CLinic Cancer Center
  • Dan P. Zandberg, MD – UPMC Hillman Cancer Center

Register Now

To view all of the ACI available sessions, click here.

Do you have additional interest in Head & Neck Cancers? SITC has a Clinical Practice Guideline (CPG) Webinar on Head and Neck Cancers coming up on Jan. 13 as well. Click here to learn more.



0 comments
4 views

Related Content

Permalink

https://www.sitcancer.org/blogs/sitc-communications/2021/12/23/immune-monitor-december-2021